title: Lymphomas in two IBD patients treated with anti-TNF-α mono or combination therapy: is hepatosplenic lymphoma really the "old maid"?
authors.forename: Tamás
authors.initials: T
authors.lastname: Molnár
authors.forename: Klaudia
authors.initials: K
authors.lastname: Farkas
authors.forename: Ferenc
authors.initials: F
authors.lastname: Nagy
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Szepes
authors.forename: Tibor
authors.initials: T
authors.lastname: Wittmann
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000188:drug therapy; D008113:Liver Neoplasms / Q000139:chemically induced / Q000175:diagnosis*; D016393:Lymphoma, B-Cell / Q000139:chemically induced / Q000175:diagnosis*; D016399:Lymphoma, T-Cell / Q000139:chemically induced / Q000175:diagnosis*; D008297:Male; D013160:Splenic Neoplasms / Q000139:chemically induced / Q000175:diagnosis*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000893:Anti-Inflammatory Agents; D014409:Tumor Necrosis Factor-alpha